TMIC-05. ABSCOPAL IMMUNE RESPONSE IN GLIOBLASTOMA ELICITED BY MIR124-ATTENUATED ONCOLYTIC HERPES SIMPLEX VIRUS 1 ARMED WITH UL16 BINDING PROTEIN 3

Glioblastoma is a deadly disease with median survival ranging below one year. T-cell-based immunotherapy approaches failed to prolong survival of glioblastoma patients in two phase III clinical trials, thus reflecting the immunologically inert features of glioblastoma. Pre-clinical efficacy of oncol...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Neuro Oncol
Egile Nagusiak: Wirsching, Hans-Georg, Zhang, Huajia, Grandi, Paola, Arora, Sonali, Cimino, Patrick J, Campbell, Jean S, Szulzewsky, Frank, Pattwell, Siobhan S, Ene, Chibawanye, Kumasaka, Debrah, Pierce, Robert H, Finer, Mitchell, Queva, Christophe, Houghton, A McGarry, Holland, Eric
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2018
Gaiak:
Abstracts
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6216323/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.1065
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak